Multimodal Imaging Market Seen Soaring 5% Growth to Reach USD 3 Million by 2030, Projects Univdatos Market Insights

According to a new report by Univdatos Market Insights, the Multimodal Imaging Market, is expected to reach USD 3 Billion in 2030 by growing at a CAGR of 5%. Multimodal Imaging is a rising sun for the opportunists who are seeking technological advancements in the healthcare sector. Multimodal imaging technique owns the potential of dominating the healthcare market owing to its importance in earlier diagnosis of deadly diseases and providing precision medicine for the same. This technique can be used to integrate two different procedures or techniques into one to obtain a detailed quality image that has precise details of the patient’s situation. With multimodal imaging, it is easier to track vitals in real-time which would help in preventing the spread of diseases like cancer which generally spread unnoticed. Also, it assists in studying pharmacokinetics or pharmacodynamics, gene expression in modal organisms, biodistribution, enzyme activity, and protein activity of a drug molecule. Popular technologies related to multimodal imaging are PET/CT, SPECT/CT, PET/MR, OCT/fundus imaging, and others. While it has applications in oncology, cardiology, neurology, orthopedics, and other sectors like rare diseases. This market is being boosted due to multiple factors like reimbursements by governments, and the integration of artificial intelligence and machine learning.

Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=46241

The report suggests that Rising Research and Development is one of the major factors driving the growth of the multimodal imaging market during the forthcoming years. Multimodal Imaging is a type of diagnostic scanning procedure that tracks diseased cells in the body. Clinical trials are essential for the development of new and modified models for multimodal imaging, as they provide valuable information on the effectiveness of imaging techniques in studying gene expression. In recent years, there has been an increasing number of clinical trials focused on multimodal imaging. For example, in 2021, China conducted a clinical trial to find the application of PET/MR imaging in the early diagnosis of Alzheimer’s disease. They are also investigating new combinations of techniques that may be more effective than existing diagnostic procedures. The increasing number of clinical trials for multimodal imaging is driving the growth of the market, as it indicates a greater interest in developing new treatments for chronic and prevalent diseases like cancer. It also provides hope for patients suffering from rare diseases for which there are no diagnostic or treatment methods available on the market.

Fig1: Ongoing Clinical Trials of Multimodal Imaging for Various Diseases, 2023

Apart from this, the penetration of artificial intelligence in medical devices has reformed the whole perspective of automation, preciseness, and data accuracy. Such technological advancements including big data analytics, machine learning, and virtual reality will also have a positive impact on the market’s growth during the forecast period. Another astounding advancement is the development of multimodal ophthalmic imaging systems, which potentially enhance contrast as well as resolution of OCT (optical coherence tomography) images. It is developed by merging several optic and acoustic technologies. For instance, in April 2022, Japan-based company Topcon Healthcare launched a fully automated all-in-one digital refraction system- ‘Chronos’ in the market. This revolutionary refraction system is a combination of a fully automated lensometer with a full-range spectrometer which can obtain highly precise and automated extensive lens measurement results.

Health tracking devices to bring a blow in the market

Tracking fitness has become another popular trend across the world. Integration of multimodal imaging features in wearable devices has presented technology in a very sleek manner. This has gained the interest of most people who like tracking their health status throughout the day. Here are some key points to understand why health-tracking devices are gaining attention in the multimodal imaging market:

Precision in life: Fitness tracking devices are designed to bring out accurate status of vitals, like blood pressure, oxygen concentration, and sleeping hours. It has eased out the way of managing health alongside workflow.

Unmet Need: The present-day scenario has created a rift between health and profession with chaotic work schedules. Fitness trackers are designed to bridge this gap between major necessities in human life.

Convenience through Notifications: Fitness trackers remind the users about their lack of attention towards their health. It also reminds if the user needs any medication to improve their health.

Patient Survival and Quality of Life: Because they are often designed to provide more precise details of health status, fitness trackers may offer improved quality of life for people by helping maintain their health.

Click here to view the Report Description & TOC https://univdatos.com/report/multimodal-imaging-market-2/

Conclusion

The global multimodal imaging market is a rapidly growing field, with advancements in technology and treatments leading to improved outcomes for patients. Multimodal Imaging is a type of advanced imaging technique designed to add accuracy and convenience to the lives of medical professionals as well as patients. The global multimodal imaging market is expected to continue to grow in the coming years. Overall, the global multimodal imaging market represents a significant opportunity for MedTech companies and professionals in the field of diagnostic imaging. With continued research and development, it is likely that even more effective and personalized treatments will become available in the future, leading to improved outcomes for patients with multimodal imaging.